- Home
- SKYW vs KZR Comparison
SKYW vs KZR Comparison
Compare SKYW & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKYW | KZR |
|---|---|---|
| Founded | 1972 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 45.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SKYW | KZR |
|---|---|---|
| Price | $101.11 | $6.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $124.75 | $6.00 |
| AVG Volume (30 Days) | ★ 284.7K | 29.1K |
| Earning Date | 01-29-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.86 | N/A |
| EPS | ★ 10.47 | N/A |
| Revenue | ★ $3,978,113,000.00 | N/A |
| Revenue This Year | $16.39 | N/A |
| Revenue Next Year | $4.36 | N/A |
| P/E Ratio | $9.61 | ★ N/A |
| Revenue Growth | ★ 19.27 | N/A |
| 52 Week Low | $74.70 | $3.53 |
| 52 Week High | $135.57 | $6.93 |
Technical Indicators
Market Signals| Indicator | SKYW | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 47.18 | 52.89 |
| Support Level | $101.56 | $6.22 |
| Resistance Level | $103.02 | $6.37 |
| Average True Range (ATR) | 2.54 | 0.11 |
| MACD | -0.50 | -0.02 |
| Stochastic Oscillator | 13.29 | 43.18 |
Price Performance
Historical ComparisonAbout SKYW SkyWest Inc.
SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. Generally, SkyWest provides regional flights, and utilizes its smaller, lower-cost aircraft to carry passengers that booked tickets through airlines. It partners with carriers across the world to fly and operate aircraft for a fee. SkyWest may use the carriers's brand and ground support to coordinate marketing and easily transport passengers. The company has two reportable segments: SkyWest Airlines, which generates maximum revenue, and SkyWest Leasing.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.